RESUMEN
Assessment of activity levels of radionuclides that exist in soil, granite, and charnockite rock samples is very crucial because it exhibits an enhanced elemental concentration of uranium (U) and thorium (Th) contributing higher natural background activity than usual in the environment and it may cause health risk to human health through the external and internal exposure. This study determined the radioactivity levels of 238U, 232Th, and 40K radionuclides in soil, granite, and charnockite rock samples collected from selected fields in Ekiti State, Nigeria using Caesium iodide CsI(Tl) scintillation gamma spectrometer. It also evaluated indices of the radiological parameters consisting of radium equivalent activity (Raeq), absorbed dose rate (DR), annual effective dose equivalent (AEDE), internal hazard index (Hin), and excess lifetime cancer risk (ELCR). The calculated average activity concentrations of 238U, 232Th, and 40K are 30.40 ± 0.71 Bq kg-1, 3.31 ± 0.05 Bq kg-1, and 222.25 ± 14.72 Bq kg-1, respectively, which were lower than their respective world average values. Comparatively, potassium concentrations in these collected samples have a higher value than concentrations of uranium and thorium (40K > 238U > 232Th). All the evaluated values of the radiological parameters (except DR) of the appraised radionuclides were below the global permissible limits. The granite rocks, charnockite rocks, and soils from Ekiti State in Nigeria do not pose any hazardous risk to humans, but continued monitoring is necessary when these materials are used as building materials, which cause long-term radiation exposure.
RESUMEN
The field of cancer nanotheranostics is rapidly evolving, with cyclodextrin (CD)-based nanoparticles emerging as a promising tool. CDs, serving as nanocarriers, have higher adaptability and demonstrate immense potential in delivering powerful anti-cancer drugs, leading to promising and specific therapeutic outcomes for combating various types of cancer. The unique characteristics of CDs, combined with innovative nanocomplex creation techniques such as encapsulation, enable the development of potential theranostic treatments. The review here focuses mainly on the different techniques administered for effective nanotheranostics applications of CD-associated complex compounds in the domain of cancer treatments. The experimentations on various loaded drugs and their complex conjugates with CDs prove effective in in vivo results. Various cancers can have potential nanotheranostics cures using CDs as nanoparticles along with a highly efficient process of nanocomplex development and a drug delivery system. In conclusion, nanotheranostics holds immense potential for targeted drug delivery and improved therapeutic outcomes, offering a promising avenue for revolutionizing cancer treatments through continuous research and innovative approaches.
RESUMEN
Numerous factors can contribute to the development of neurodegenerative disorders (NDs), such as Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, Huntington's disease, and multiple sclerosis. Oxidative stress (OS), a fairly common ND symptom, can be caused by more reactive oxygen species being made. In addition, the pathological state of NDs, which includes a high number of protein aggregates, could make chronic inflammation worse by activating microglia. Carotenoids, often known as "CTs", are pigments that exist naturally and play a vital role in the prevention of several brain illnesses. CTs are organic pigments with major significance in ND prevention. More than 600 CTs have been discovered in nature, and they may be found in a wide variety of creatures. Different forms of CTs are responsible for the red, yellow, and orange pigments seen in many animals and plants. Because of their unique structure, CTs exhibit a wide range of bioactive effects, such as anti-inflammatory and antioxidant effects. The preventive effects of CTs have led researchers to find a strong correlation between CT levels in the body and the avoidance and treatment of several ailments, including NDs. To further understand the connection between OS, neuroinflammation, and NDs, a literature review has been compiled. In addition, we have focused on the anti-inflammatory and antioxidant properties of CTs for the treatment and management of NDs.
RESUMEN
OBJECTIVES: This study aims to first measure patient doses during computed tomography (CT) chest, abdomen, and extremities procedures for evaluation lymphedema, and second to estimate the radiation dose-related risks during the procedures. MATERIAL AND METHODS: Radiation effective doses from CT lymphography procedures quantified using CT machines from different vendors. After the calibration of CT systems, the data collected for a total of 28 CT lymphography procedures. Effective and organ doses extrapolated using national radiological protection software based on Monte Carlo simulation. RESULTS: The mean patient doses for chest and abdomen procedures in term of CTDIvol (mGy) and DLP (mGy.cm) are 10.0 ± 3 and 425 ± 222 and 24 ± 12 and 1118 ± 812 for CT 128 and CT 16 slice, respectively. The mean DLP (mGy.cm) for extremities was 320 ± 140 and 424 ± 212 for CT 128 and CT 16 slice, in that order. CONCLUSION: Patients' dose showed significant differences due to variation in the scan length and clinical indication. Organs lay in the primary beam received high radiation doses especially in the chest region which increases the probability of radiation-induced cancer. The current patient's doses are higher compared to the previous studies.
